Scottsdale TMS Therapy, a psychiatry clinic in Arizona, has expanded its treatment options by incorporating FDA-approved Spravato (esketamine) nasal spray for adults with treatment-resistant depression. This addition addresses a critical gap for patients who do not respond to conventional antidepressants, which often require weeks to show effects. Esketamine, by contrast, can reduce depressive symptoms within days, offering a faster pathway to relief.
The clinic, already known for transcranial magnetic stimulation (TMS) protocols, now provides a broader scope of interventional psychiatry. Esketamine works by modulating NMDA receptors in the brain, promoting neuroplasticity—the formation of new neural connections that support emotional regulation. This mechanism differs from standard oral antidepressants that adjust neurotransmitter levels, which may be ineffective for complex mood disorders.
"When standard medications fail to deliver remission, it is an indication that the underlying neural networks require a different mechanism of stimulation," stated a spokesperson for Scottsdale TMS Therapy. "Spravato represents a major milestone in complex mood disorder care. Because it can reduce persistent depressive symptoms and decrease suicidal ideation within days rather than weeks, it serves as an immediate lifeline that restores cognitive flexibility and prepares patients for long-term psychological stabilization."
As a tightly regulated medication, esketamine is administered in a controlled outpatient setting. Scottsdale TMS Therapy is a fully REMS-certified clinic, meeting federal safety standards. Each session includes pre-treatment health screenings, supervised self-administration, and a mandatory two-hour observation period with continuous monitoring of blood pressure and vital signs. The clinic provides a comfort-focused environment with Apollo TMS chairs, private treatment rooms, an on-site cafe, and an outdoor patio to minimize patient stress.
To support access, the clinic works with major commercial insurers and manages the authorization process internally. Individuals seeking guidance on interventional options for severe major depressive disorder can contact the clinical admissions team for confidential consultations and same-day insurance verification.
For more information, visit Scottsdale TMS Therapy.
